China Biotech's two new coronavirus Omicron inactivated vaccines received clinical approval from Hong Kong Junshi Bio's new crown oral drug VV116 released the latest research results

Key Data Concepts:   

? These are the company names, stock quotes, topics, and entities related to this data.

000518 000908 002014 002349 002603 002750 002864 002901 002932 300142 300630 Bio-Thera Solutions China Meheco Group China Resources Double-Crane Pharmaceutical China Shipbuilding Industry Group Power Citic Securities Dali Pharmaceutical Double Medical Technology Fujian Funeng Hainan Poly Pharm Huangshan Novel Hunan Jingfeng Pharmaceutical Jiangsu Hengrui Medicine Jiangsu Sihuan Bioengineering Jinghua Pharmaceutical Group Kunming Longjin Pharmaceutical Nanjing King-Friend Biochemical Pharmaceutical Shaanxi Panlong Pharmaceutical Group Limited By Share Shijiazhuang Yiling Pharmaceutical Walvax Biotechnology Wuhan Easy Diagnosis Biomedicine Xinjiang Sayram Modern Agriculture Zhejiang Cheng Yi Pharmaceutical Arts, Culture, Entertainment, Media Accounting, Audit Strategy, Marketing Board Of Directors Patent, Copyright, Trademark Research, Development Health, Beauty Product Pharmaceutical Construction, Property Energy, Resource Electricity Production, Distribution Financial, Business Service Media Market, Exchange Stocks University Nature Diseases, Conditions Cancer Injury Hospital Medicine Traditional Chinese Medicine, Tcm Vaccines Health

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Home » News » China Biotech's two new coronavirus Omicron inactivated vaccines received clinical approval from Hong Kong Junshi Bio's new crown oral drug VV116 released the latest research results